Sat Kartar Life Gets NSE Approval for 50,400 Shares

NSE clears trading in preferential shares

Sat Kartar Life Limited has received approval from the National Stock Exchange of India Limited to list and trade 50,400 equity shares issued on a preferential basis to non-promoters. The NSE conveyed the approval through a letter dated July 6, 2026. The shares were admitted to dealings on the exchange from July 7, 2026. The approval completes the listing step for this specific tranche of equity shares after their preferential allotment. The shares carry a lock-in period until January 29, 2027. This means the allotted shares can trade on the exchange but remain subject to the stated lock-in condition.

What the exchange approval covers

The approval applies specifically to 50,400 equity shares allotted under the non-promoter category. These are equity shares of face value of Rs 10 each, as indicated in the company’s earlier NSE in-principle approval disclosure. The shares were issued through the preferential route rather than a public issue. Preferential issuances allow listed companies to allot securities to identified investors, subject to shareholder approval and exchange and regulatory requirements. In this case, the NSE has allowed the allotted shares to be listed and admitted for trading from July 7. The approval does not refer to any change in the company’s trading price or market performance.

Key details of the listing approval

Link to the May in-principle approval

The July listing approval follows the NSE’s in-principle approval dated May 8, 2026. That earlier approval was issued under Regulation 28(1) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It covered 50,400 equity shares and up to 27,74,400 equity shares that could be issued upon conversion of preferential warrants. Sat Kartar Life had submitted its application to the NSE on April 21, 2026. The exchange’s in-principle clearance was subject to statutory, regulatory and compliance conditions before final listing could occur. The approval for 50,400 shares marks the listing and trading clearance for the equity-share component covered by that process.

Shareholder approval supported the issue

Sat Kartar Life held an extraordinary general meeting through video conferencing on May 13, 2026. Shareholders passed special resolutions relating to the preferential issue of equity shares and warrants to non-promoters. The company reported 1,04,35,956 votes in favour of each of the two resolutions. No votes were recorded against either resolution. The resolutions therefore received 100% support among votes cast. The company submitted the voting results and scrutinizer’s report to the NSE under Regulation 30 of the SEBI LODR Regulations.

Wider preferential fundraising structure

The company’s disclosed fundraising structure included both direct equity shares and convertible warrants. A company presentation described a preferential issue of 50,400 equity shares and 27.74 lakh convertible warrants at Rs 172 per equity share or warrant, with a total proposed size of Rs 48.58 crore. The presentation referred to participation by 15 investors, led by Lighthouse Canton. Separately, the company reported the allotment of 26,95,200 convertible warrants to 14 investors on May 27, 2026. Those warrants were also issued at Rs 172 each, including a premium of Rs 162 per warrant.

Warrant allotment and upfront payment

Under the May 27 warrant allotment, 25% of the issue price was payable upfront. Sat Kartar Life reported receipt of Rs 11.59 crore, or Rs 11,58,93,600, representing that upfront portion. Each warrant carried the right to subscribe to one equity share of face value Rs 10, subject to the applicable conversion terms. The warrant structure is separate from the 50,400 equity shares now admitted to trading. Any equity shares issued through warrant conversion would require the relevant conditions and listing processes to be met. Investors should therefore distinguish between the listed 50,400-share tranche and the potential shares linked to outstanding warrants.

Why the lock-in period matters

A lock-in period restricts the transfer or sale of allotted securities for the specified duration. For the 50,400 shares, the lock-in runs until January 29, 2027. The condition is relevant because the shares have been admitted to trading while continuing to be subject to this restriction. The lock-in is part of the disclosed terms associated with the preferential allotment. It does not change the number of shares approved for listing. The company’s July disclosure identifies the date clearly, allowing investors to track the applicable restriction period.

Market and investor relevance

The approval adds 50,400 equity shares to the listed securities admitted for dealings on the NSE. It also shows that the company has progressed from board and shareholder approvals to exchange clearance for this portion of its preferential issue. No share-price movement, revised earnings guidance or operating impact was disclosed alongside the trading approval. The available information instead relates to the mechanics of the capital-raising process. For investors, the key facts are the number of approved shares, their non-promoter allottee status, the July 7 trading date and the lock-in ending January 29, 2027.

Subsequent warrant proposal

On September 30, 2026, Sat Kartar Life’s board approved a separate proposed preferential issue of up to 5,50,000 convertible warrants at Rs 172 each. The proposed issue was valued at Rs 9.46 crore and was intended for three promoter-group allottees, subject to shareholder and regulatory approvals. The company scheduled an extraordinary general meeting for October 23, 2026, with October 16 set as the record date. This later proposal is distinct from the 50,400 non-promoter equity shares approved for trading in July. It illustrates the company’s continued use of preferential securities as a funding route, while each issuance remains subject to its own approvals and conditions.

Conclusion

Sat Kartar Life’s 50,400 preferential equity shares for non-promoters began trading on the NSE on July 7, 2026, following the exchange’s July 6 approval. The shares remain under lock-in until January 29, 2027. The listing clearance is linked to the company’s broader preferential issue process approved by shareholders in May. Investors can monitor future disclosures on warrant conversions and the separately proposed promoter-group warrant issue.